LVLucio Vera-Cabrera

Lucio Vera-Cabrera

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lucio Vera-Cabrera has a total of 209 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    In vitro activity of omadacycline and eravacycline against Nocardia brasiliensis isolates

    by Ramírez- Marín, Hassiel Aurelio Aurelio, Jorge Ocampo-Candiani, Lucio Vera-Cabrera

    Actinomycetoma is a chronic, debilitating, neglected tropical disease primarily caused by Nocardia brasiliensis in Mexico and Central America. Current therapeutic standards involving high-dose trimethoprim–sulfamethoxazole are often complicated by significant toxicity and the requirement for long-term administration, highlighting an urgent need for effective oral alternatives. This study was undertaken to evaluate the potential of third-generation tetracyclines as superior therapeutic candidates. This study assessed the in vitro activity of omadacycline and eravacycline against 50 clinical isolates of Nocardia brasiliensis from human actinomycetoma cases. Susceptibility testing was done using E-test strips with omadacycline, eravacycline, and three other antimicrobials that served as comparators (trimethoprim–sulfamethoxazole, tigecycline, and minocycline). Eravacycline exhibited the highest potency (MIC 50 /MIC 90 : 0.047/0.094 μg/mL), significantly lower than omadacycline (1.0/1.5 μg/mL) and trimethoprim–sulfamethoxazole (0.19/1.0 μg/mL). These results demonstrate that eravacycline is a highly potent, promising oral therapeutic option for actinomycetoma. This work represents a major conceptual advance by identifying a highly active candidate that, due to its favorable pharmacokinetics and oral bioavailability, could transform clinical management in rural endemic regions by facilitating outpatient therapy and improving patient adherence. Further clinical validation through in vivo studies is now required to confirm these promising in vitro findings.

  • Cutaneous botryomycosis: a comprehensive review

    by Karen Yaresi Ramos-Reza, Maria Fernanda Ortiz-Nuño, Alexandro Bonifaz, Jorge Ocampo-Candiani, Lucio Vera-Cabrera, Dionicio Angel Galarza-Delgado, Jesus Alberto Cardenas-De la Garza

    Purpose Cutaneous botryomycosis is a chronic, granulomatous infection of the skin caused by different bacteria that form granular aggregates. We aim to provide a complete, comprehensive, and updated review of cutaneous botryomycosis, including a review of cases published in the last decade. Results Patients with botryomycosis typically present multiple nodules, sinuses, abscesses, fistulae, and ulcers, which develop during weeks or months. The current gold standard for diagnosing botryomycosis involves a combination of histopathological examination and microbial culture. A definitive diagnosis is established when clinical and pathological findings align with the presence of botryomycosis, supported by the identification of non-filamentous bacteria forming granules and positive culture. The most frequent isolated etiological agents are Staphylococcus aureus followed by Pseudomonas aeruginosa. The differential diagnosis includes mycetoma, actinomycosis, and carcinomas/sarcomas. Treatment includes antibiotics and, in selected cases, surgical debridement.

  • Pre-European contact leprosy in the Americas and its current persistence

    by Maria Lopopolo, Charlotte Avanzi, Sebastian Duchene, Pierre Luisi, Alida de Flamingh, Gabriel Yaxal Ponce-Soto, Gaetan Tressieres, Sarah Neumeyer, Frédéric Lemoine, Elizabeth A. Nelson, et al.

    Leprosy, caused primarily by Mycobacterium leprae , is considered a disease introduced into the Americas during European colonization. However, the recent discovery of a second pathogen causing leprosy, M. lepromatosis , mainly found in the Americas, challenges this view. Here, we show that M. lepromatosis infected humans in the Americas before European contact. By screening 389 ancient and 408 contemporary samples, we have expanded the genetic data available for the species. Phylogenetic analyses revealed distinct human-infecting clades of M. lepromatosis , with one dominating North America since colonial times. The presence of millennia-old strains in North and South America indicates that M. lepromatosis may have been widespread during the Late Holocene, demonstrating that M. lepromatosis leprosy has a long-standing history in the Americas before European arrival.


  • Immune response in BALB/c mice to an attenuated strain of Nocardia brasiliensis

    by Kevin A. Flores-Aldaba, Anna V. Vázquez-Marmolejo, Javier Vargas-Villarreal, Jorge Ocampo-Candiani, Mayra G. Cantú-Álvarez, Pablo E. Espinoza-Martínez, Mario C. Salinas-Carmona, Lucio Vera-Cabrera

  • Open Access

    Actinomadura welshii sp. nov., a New Mycetoma Agent in Mexico

    by Lucio Vera-Cabrera, Carmen A. Molina-Torres, Adele E. Crane, Mayra G. Cantú-Alvarez, Mario A. Aguilera-Valenciano, Anabel Gallardo-Rocha, Wendy G. Escalante-Fuentes, Jorge Ocampo-Candiani, Charlotte Avanzi

    Actinomadura isolates obtained from seven human mycetoma cases in Mexico were characterized using nucleotide sequence analysis of a portion of the small subunit ribosomal RNA gene. Most isolates were identified as Actinomadura madurae. However, one isolate, LIID-AQ337, showed inconclusive results. To determine its identity, genomic DNA from LIID-AQ337 was subjected to whole-genome sequencing using both short- and long-read sequencing, resulting in a genome of 8,163,638-bp spread in 22 contigs. Comparative analysis against currently available genomes of other Actinomadura species suggested that LIID-AQ337 belongs to a new Actinomadura species. We propose to name it Actinomadura welshii sp. nov in honor of Oliverio Welsh, a Mexican dermatologist dedicated to mycetoma studies in Mexico.


  • Open Access

    Isolation and characterization of nontuberculous mycobacteria in drinking water of Monterrey, Mexico

    by Fanny Cecilia Cordero-Martinez, Lucio Vera-Cabrera, Jorge Ocampo-Candiani, Edith Dariela Riojas-Hernández, Carmen Amelia Molina-Torres

  • Open Access

    Kerion celsi causado por Trichophyton tonsurans em adulto

    by Jacqueline Paulina Aguirre Sotelo, Víctor Manuel Tarango Martinez, Lucio Vera Cabrera

  • Open Access

    Kerion celsi caused by Trichophyton tonsurans in an adult

    by Jacqueline Paulina Aguirre Sotelo, Víctor Manuel Tarango Martinez, Lucio Vera Cabrera


  • Open Access

    Genetic Diversity of Mycobacterium tuberculosis Isolates From an Amerindian Population in Chiapas, México

    by Carmen A. Molina-Torres, Frederick D. Quinn, Jorge Castro-Garza, Anaximandro Gómez-Velasco, Jorge Ocampo-Candiani, Alied Bencomo-Alerm, Héctor Javier Sánchez-Pérez, Sergio Muñoz-Jiménez, Adrián Rendón, Afzal Ansari, et al.

    This is the first report of the genetic diversity of the Mycobacterium tuberculosis complex isolates found in a Mexican-Amerindian setting. In this study, we analyzed isolates collected from the Highlands region of Chiapas, Mexico, by using spoligotyping and whole-genome sequencing analyses. Seventy-three M. tuberculosis isolates were analyzed initially by spoligotyping; no new spoligotypes were identified. Nineteen percent of the isolates were identified as SIT53 (T1) (n = 14), followed by SIT42 (14%, n = 10, LAM9) and SIT119 (11%; n = 8, X1). SIT53, SIT42, and orphan isolates (16.4%, n = 12) constituted about 50% of the isolates studied and were subjected to whole-genome sequencing (WGS) analysis. Most SIT53 (10/12) isolates belonged to the Euro-American sub-lineage 4.8. Most SIT42 isolates (4/7) as .well as most orphan isolates (5/8) belonged to the lineage 4.3.3 LAM group. By comparing the single-nucleotide polymorphism (SNP) patterns of the SIT53 isolates, we found one clone (<7 SNPs) and four clustered isolates (<15 SNPs). In isolates from the SIT42 and orphan groups, we did not find any clones or clusters. This work demonstrates the success of sub-lineage 4.8 to predominate in Mexico and confirms the dominion of sub-lineage 4.3.3 in Central and South America.


  • Open Access

    Mycobacterium leprae Infection in a Wild Nine-Banded Armadillo, Nuevo León, Mexico

    by Lucio Vera-Cabrera, Cesar J. Ramos-Cavazos, Nathan A. Youssef, Camron M. Pearce, Carmen A. Molina-Torres, Ramiro Avalos-Ramirez, Sebastien Gagneux, Jorge Ocampo-Candiani, Mercedes Gonzalez-Juarrero, Jorge A. Mayorga-Rodriguez, et al.

    Nine-banded armadillos (Dasypus novemcinctus) are naturally infected with Mycobacterium leprae and are implicated in the zoonotic transmission of leprosy in the United States. In Mexico, the existence of such a reservoir remains to be characterized. We describe a wild armadillo infected by M. leprae in the state of Nuevo León, Mexico.